Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INEBILIZUMAB Cause Covid-19? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Covid-19 have been filed in association with INEBILIZUMAB (UPLIZNA). This represents 10.6% of all adverse event reports for INEBILIZUMAB.

7
Reports of Covid-19 with INEBILIZUMAB
10.6%
of all INEBILIZUMAB reports
0
Deaths
7
Hospitalizations

How Dangerous Is Covid-19 From INEBILIZUMAB?

Of the 7 reports, 7 (100.0%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Covid-19 Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INEBILIZUMAB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does INEBILIZUMAB Cause?

Off label use (20) Neuromyelitis optica spectrum disorder (17) Pneumocystis jirovecii pneumonia (7) Pneumonia (6) Pyrexia (6) Progressive multifocal leukoencephalopathy (5) Respiratory failure (5)

What Other Drugs Cause Covid-19?

NIRMATRELVIR\RITONAVIR (22,066) OCRELIZUMAB (11,454) ADALIMUMAB (9,138) DUPILUMAB (6,986) RITUXIMAB (6,301) LENALIDOMIDE (6,223) TOFACITINIB (4,926) SECUKINUMAB (3,871) INFLIXIMAB (3,698) TACROLIMUS (3,201)

Related Pages

INEBILIZUMAB Full Profile All Covid-19 Reports All Drugs Causing Covid-19 INEBILIZUMAB Demographics